Your browser doesn't support javascript.
loading
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
Rugo, Hope S; Bardia, Aditya; Marmé, Frederik; Cortes, Javier; Schmid, Peter; Loirat, Delphine; Trédan, Olivier; Ciruelos, Eva; Dalenc, Florence; Pardo, Patricia Gómez; Jhaveri, Komal L; Delaney, Rosemary; Fu, Olivia; Lin, Lanjia; Verret, Wendy; Tolaney, Sara M.
Affiliation
  • Rugo HS; Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • Bardia A; Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
  • Marmé F; Medical Faculty Mannheim, Heidelberg University, University Hospital Mannheim, Heidelberg, Germany.
  • Cortes J; Medical Oncology Department, International Breast Cancer Center, Pangaea Oncology, Quironsalud Group, Madrid and Barcelona, Spain.
  • Schmid P; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • Loirat D; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Trédan O; Medical Oncology Department and D3i, Institut Curie, Paris, France.
  • Ciruelos E; Medical Oncology Department, Centre Léon Bérard, Lyon, France.
  • Dalenc F; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Pardo PG; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Jhaveri KL; Hospital Universitari Vall D'Hebron, Barcelona, Spain.
  • Delaney R; Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Fu O; Department of Clinical Development, Gilead Sciences Inc, Foster City, CA.
  • Lin L; Department of Global Patient Safety, Gilead Sciences Inc, Foster City, CA.
  • Verret W; Department of Biostatistics, Gilead Sciences Inc, Foster City, CA.
  • Tolaney SM; Department of Clinical Development, Gilead Sciences Inc, Foster City, CA.
J Clin Oncol ; 40(29): 3365-3376, 2022 10 10.
Article in En | MEDLINE | ID: mdl-36027558
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Type of study: Clinical_trials Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Immunoconjugates Type of study: Clinical_trials Limits: Female / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Affiliation country: Canada Country of publication: United States